Skip to content

Clinical trials

Terminated Phase 2 Burkitt Lymphoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Burkitt Lymphoma Phase: Phase 2 Status: Terminated Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20053
20061
20081
20092
20104
20112
20121
20133
20141
20151
20172
20182
20192
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated32

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center4
Fred Hutchinson Cancer Center3
Masonic Cancer Center, University of Minnesota2
National Cancer Institute (NCI)2
Alliance for Clinical Trials in Oncology1
Barbara Ann Karmanos Cancer Institute1
Brown University1
Case Comprehensive Cancer Center1
City of Hope Medical Center1
Dana-Farber Cancer Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Burkitt Lymphoma32
Precursor Cell Lymphoblastic Leukemia-Lymphoma21
Lymphoma, Large B-Cell, Diffuse15
Lymphoma, Mantle-Cell14
Lymphoma, Follicular13
Lymphoma, B-Cell, Marginal Zone12
Lymphoma, Non-Hodgkin12
Leukemia, Lymphocytic, Chronic, B-Cell10
Leukemia, Myeloid, Acute10
Lymphoma, Large-Cell, Immunoblastic10

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.